Sangamo Therapeutics at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

Sangamo Therapeutics brings 2 presentations to AAPS 2026 PharmSci 360 in New Orleans. Sangamo Therapeutics' program centres on characterization and modeling in manufacturing. Its work covers structural and biophysical analysis of lipid nanoparticles and biosimilars, and digital transformation built on mechanistic modeling and quality by design.

OrganizationAAPS 2026 PharmSci 360 Attendance
sangamo.com
Biotech
Genomic medicine company using zinc finger technology to develop treatments for neurological and rare genetic diseases.
Session
Tue Oct 27
9:00am–11:00am
Symposium: Advanced Structural and Biophysical Characterization of Lipid Nanoparticle Systems and Biosimilars
Manufacturing and Analytical Characterization
Session
Wed Oct 28
9:00am–11:00am
Symposium: Digital Transformation Through Mechanistic Modeling, QbD, and Collaborative Innovation
Manufacturing and Analytical Characterization

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Sangamo Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction